Rank | Gene Set | Z-score |
---|---|---|
1 | pre-miRNA processing (GO:0031054) | 4.04640673 |
2 | regulation of translational termination (GO:0006449) | 4.00706802 |
3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.00158069 |
4 | negative regulation of cell killing (GO:0031342) | 4.00158069 |
5 | response to peptidoglycan (GO:0032494) | 3.98096580 |
6 | positive regulation by symbiont of host defense response (GO:0052509) | 3.93579537 |
7 | modulation by symbiont of host defense response (GO:0052031) | 3.93579537 |
8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.93579537 |
9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.93579537 |
10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.93579537 |
11 | modulation by symbiont of host immune response (GO:0052553) | 3.93579537 |
12 | NIK/NF-kappaB signaling (GO:0038061) | 3.64602301 |
13 | heterochromatin organization (GO:0070828) | 3.53913353 |
14 | regulation of translational fidelity (GO:0006450) | 3.43162180 |
15 | positive regulation of histone deacetylation (GO:0031065) | 3.38052621 |
16 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.32923138 |
17 | macrophage activation involved in immune response (GO:0002281) | 3.32904985 |
18 | stress fiber assembly (GO:0043149) | 3.30837234 |
19 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.29187841 |
20 | positive regulation of lamellipodium assembly (GO:0010592) | 3.28797678 |
21 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.28781900 |
22 | regulation of early endosome to late endosome transport (GO:2000641) | 3.28661211 |
23 | negative regulation of cell size (GO:0045792) | 3.27349906 |
24 | response to muramyl dipeptide (GO:0032495) | 3.27232720 |
25 | negative regulation of interleukin-12 production (GO:0032695) | 3.26912500 |
26 | * protein localization to endosome (GO:0036010) | 3.21877481 |
27 | negative regulation of histone methylation (GO:0031061) | 3.19847668 |
28 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.18793969 |
29 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.16938655 |
30 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.16214560 |
31 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.15041374 |
32 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.14257355 |
33 | mitotic G1 DNA damage checkpoint (GO:0031571) | 3.13682360 |
34 | modulation by symbiont of host cellular process (GO:0044068) | 3.13382569 |
35 | peptidyl-lysine dimethylation (GO:0018027) | 3.06756243 |
36 | RNA stabilization (GO:0043489) | 3.05436167 |
37 | mRNA stabilization (GO:0048255) | 3.05436167 |
38 | mannose metabolic process (GO:0006013) | 3.04353256 |
39 | intracellular estrogen receptor signaling pathway (GO:0030520) | 3.03659122 |
40 | barbed-end actin filament capping (GO:0051016) | 3.03318832 |
41 | maternal placenta development (GO:0001893) | 3.02575484 |
42 | adherens junction assembly (GO:0034333) | 3.01196838 |
43 | peptidyl-arginine N-methylation (GO:0035246) | 3.00247336 |
44 | peptidyl-arginine methylation (GO:0018216) | 3.00247336 |
45 | regulation of RNA export from nucleus (GO:0046831) | 2.99331085 |
46 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.99316550 |
47 | detection of other organism (GO:0098543) | 2.98652688 |
48 | regulation of hippo signaling (GO:0035330) | 2.98541529 |
49 | germinal center formation (GO:0002467) | 2.98362486 |
50 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.98315021 |
51 | NLS-bearing protein import into nucleus (GO:0006607) | 2.97357158 |
52 | pinocytosis (GO:0006907) | 2.96839697 |
53 | trophectodermal cell differentiation (GO:0001829) | 2.94940986 |
54 | apoptotic process involved in morphogenesis (GO:0060561) | 2.92500573 |
55 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.91579445 |
56 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.91559610 |
57 | nuclear pore complex assembly (GO:0051292) | 2.91356747 |
58 | protein localization to kinetochore (GO:0034501) | 2.90310383 |
59 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.89898679 |
60 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.85748055 |
61 | detection of bacterium (GO:0016045) | 2.84690727 |
62 | cell-substrate adherens junction assembly (GO:0007045) | 2.81302413 |
63 | focal adhesion assembly (GO:0048041) | 2.81302413 |
64 | myeloid dendritic cell differentiation (GO:0043011) | 2.80786130 |
65 | regulation of leukocyte degranulation (GO:0043300) | 2.80490958 |
66 | neutrophil activation involved in immune response (GO:0002283) | 2.79442584 |
67 | COPI coating of Golgi vesicle (GO:0048205) | 2.79090315 |
68 | Golgi transport vesicle coating (GO:0048200) | 2.79090315 |
69 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.77423099 |
70 | positive regulation of lamellipodium organization (GO:1902745) | 2.76212974 |
71 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.75156878 |
72 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.75041236 |
73 | detection of molecule of bacterial origin (GO:0032490) | 2.73074026 |
74 | sodium ion export (GO:0071436) | 2.72924864 |
75 | mitotic G1/S transition checkpoint (GO:0044819) | 2.71234179 |
76 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.70750946 |
77 | modulation by virus of host process (GO:0019054) | 2.69610333 |
78 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.69350640 |
79 | regulation of gene silencing by miRNA (GO:0060964) | 2.69350640 |
80 | regulation of gene silencing by RNA (GO:0060966) | 2.69350640 |
81 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.68961093 |
82 | positive thymic T cell selection (GO:0045059) | 2.68752986 |
83 | activation of MAPKKK activity (GO:0000185) | 2.68697403 |
84 | nuclear pore organization (GO:0006999) | 2.67920819 |
85 | type I interferon signaling pathway (GO:0060337) | 2.67269764 |
86 | cellular response to type I interferon (GO:0071357) | 2.67269764 |
87 | cortical actin cytoskeleton organization (GO:0030866) | 2.66549742 |
88 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.64693473 |
89 | detection of external biotic stimulus (GO:0098581) | 2.64565308 |
90 | response to type I interferon (GO:0034340) | 2.64307430 |
91 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.62887286 |
92 | plasma membrane repair (GO:0001778) | 2.62708344 |
93 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.62599025 |
94 | regulation of ARF GTPase activity (GO:0032312) | 2.62256834 |
95 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.61619299 |
96 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.60772821 |
97 | leukocyte aggregation (GO:0070486) | 2.59795287 |
98 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.58262126 |
99 | negative regulation of nucleotide catabolic process (GO:0030812) | 2.57670898 |
100 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.55745141 |
101 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.55680766 |
102 | response to host (GO:0075136) | 2.55680766 |
103 | response to host defenses (GO:0052200) | 2.55680766 |
104 | DNA unwinding involved in DNA replication (GO:0006268) | 2.55395110 |
105 | nuclear envelope disassembly (GO:0051081) | 2.55238656 |
106 | membrane disassembly (GO:0030397) | 2.55238656 |
107 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.55101522 |
108 | chromatin assembly (GO:0031497) | 2.55064236 |
109 | regulation of mast cell degranulation (GO:0043304) | 2.54476211 |
110 | dosage compensation (GO:0007549) | 2.54268954 |
111 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.54234639 |
112 | mitotic nuclear envelope disassembly (GO:0007077) | 2.52709554 |
113 | regulation of defense response to virus by virus (GO:0050690) | 2.51423260 |
114 | response to laminar fluid shear stress (GO:0034616) | 2.51349213 |
115 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.51323890 |
116 | establishment of apical/basal cell polarity (GO:0035089) | 2.51028023 |
117 | positive regulation of protein deacetylation (GO:0090312) | 2.50915464 |
118 | G1 DNA damage checkpoint (GO:0044783) | 2.50517665 |
119 | response to host immune response (GO:0052572) | 2.50092642 |
120 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.50092642 |
121 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.49993899 |
122 | immunoglobulin mediated immune response (GO:0016064) | 2.48997837 |
123 | regulation of superoxide anion generation (GO:0032928) | 2.48663643 |
124 | activation of Rac GTPase activity (GO:0032863) | 2.48539160 |
125 | embryonic process involved in female pregnancy (GO:0060136) | 2.47898479 |
126 | signal complex assembly (GO:0007172) | 2.47523882 |
127 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.46878215 |
128 | regulation of necroptotic process (GO:0060544) | 2.45941382 |
129 | corticosteroid receptor signaling pathway (GO:0031958) | 2.45686956 |
130 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 2.44994843 |
131 | Fc-gamma receptor signaling pathway (GO:0038094) | 2.44994843 |
132 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 2.44994843 |
133 | histone H2A monoubiquitination (GO:0035518) | 2.44763859 |
134 | positive regulation of gene expression, epigenetic (GO:0045815) | 2.43717667 |
135 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 2.43297117 |
136 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.42930352 |
137 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.42917303 |
138 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.42747358 |
139 | thymic T cell selection (GO:0045061) | 2.41986189 |
140 | activation of JUN kinase activity (GO:0007257) | 2.41870646 |
141 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.41476244 |
142 | endothelial tube morphogenesis (GO:0061154) | 2.40998289 |
143 | morphogenesis of an endothelium (GO:0003159) | 2.40998289 |
144 | natural killer cell differentiation (GO:0001779) | 2.40621145 |
145 | glycosphingolipid catabolic process (GO:0046479) | 2.39587468 |
146 | nodal signaling pathway (GO:0038092) | 2.39491971 |
147 | histone arginine methylation (GO:0034969) | 2.39418535 |
148 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.37192168 |
149 | cellular response to virus (GO:0098586) | 2.37122021 |
150 | cell-substrate junction assembly (GO:0007044) | 2.36977018 |
151 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.36569722 |
152 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.36413496 |
153 | protein localization to chromosome, centromeric region (GO:0071459) | 2.36313253 |
154 | myeloid dendritic cell activation (GO:0001773) | 2.36156766 |
155 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.36056641 |
156 | regulation of tight junction assembly (GO:2000810) | 2.35837517 |
157 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.35801521 |
158 | cellular extravasation (GO:0045123) | 2.35032268 |
159 | negative regulation of fatty acid transport (GO:2000192) | 2.34723475 |
160 | regulation of integrin activation (GO:0033623) | 2.34279473 |
161 | regulation of gamma-delta T cell activation (GO:0046643) | 2.33827265 |
162 | positive regulation of chromosome segregation (GO:0051984) | 2.33807346 |
163 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.33485967 |
164 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.33074260 |
165 | negative regulation of heart growth (GO:0061117) | 2.33074260 |
166 | pentose-phosphate shunt (GO:0006098) | 2.33045512 |
167 | skin morphogenesis (GO:0043589) | 2.32953755 |
168 | hepatocyte apoptotic process (GO:0097284) | 2.32514223 |
169 | T cell apoptotic process (GO:0070231) | 2.32107558 |
170 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.31514464 |
171 | detection of biotic stimulus (GO:0009595) | 2.30907902 |
172 | regulation of sister chromatid cohesion (GO:0007063) | 2.30820613 |
173 | negative regulation of viral release from host cell (GO:1902187) | 2.26052282 |
174 | regulation of necrotic cell death (GO:0010939) | 2.25364484 |
175 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.24671596 |
176 | regulation of regulated secretory pathway (GO:1903305) | 2.23146753 |
177 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.21454314 |
178 | negative regulation of necroptotic process (GO:0060546) | 2.21289957 |
179 | positive regulation of leukocyte degranulation (GO:0043302) | 2.20725120 |
180 | regulation of podosome assembly (GO:0071801) | 2.20629516 |
181 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.19987185 |
182 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.19172403 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.89347435 |
2 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.83514050 |
3 | * MYC_22102868_ChIP-Seq_BL_Human | 3.64010875 |
4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.40336956 |
5 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.39435181 |
6 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.84291346 |
7 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.68037171 |
8 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.61441027 |
9 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.48009559 |
10 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.43077246 |
11 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.31362006 |
12 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.26130641 |
13 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.25091978 |
14 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.23097706 |
15 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.04346119 |
16 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.02649217 |
17 | * ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.92471281 |
18 | MAF_26560356_Chip-Seq_TH1_Human | 1.91474963 |
19 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.85004416 |
20 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.80791826 |
21 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.77518478 |
22 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.76829227 |
23 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.76343425 |
24 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.75935319 |
25 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.74484190 |
26 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.74083901 |
27 | KDM2B_26808549_Chip-Seq_K562_Human | 1.70821028 |
28 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.70536847 |
29 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.68756423 |
30 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.66389654 |
31 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.66174938 |
32 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.65009218 |
33 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.60669215 |
34 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.59699276 |
35 | ATF3_27146783_Chip-Seq_COLON_Human | 1.58119464 |
36 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.57537300 |
37 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.57262824 |
38 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.52115260 |
39 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.51130749 |
40 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.50639545 |
41 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.50291088 |
42 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.48600945 |
43 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.46983273 |
44 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.43867066 |
45 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.43119846 |
46 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.43054995 |
47 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.42144236 |
48 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.41526251 |
49 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.41514605 |
50 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.40575297 |
51 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40368978 |
52 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.39657257 |
53 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.39399965 |
54 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.39178402 |
55 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.39043762 |
56 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.37930929 |
57 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.37259962 |
58 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.35165093 |
59 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.34865698 |
60 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.33792762 |
61 | SPI1_23127762_ChIP-Seq_K562_Human | 1.33519194 |
62 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.32958012 |
63 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.32440699 |
64 | * MAF_26560356_Chip-Seq_TH2_Human | 1.31960790 |
65 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.29680604 |
66 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.29233627 |
67 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.28840971 |
68 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.28778271 |
69 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.28721224 |
70 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.28363625 |
71 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.26980667 |
72 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.26222631 |
73 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.25540229 |
74 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25504191 |
75 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.24980908 |
76 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.24850506 |
77 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.22964190 |
78 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.22364016 |
79 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.22214346 |
80 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.21559221 |
81 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.21502075 |
82 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.19882290 |
83 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.19560822 |
84 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19095813 |
85 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.19053328 |
86 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.18357465 |
87 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15285770 |
88 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.13979362 |
89 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13555890 |
90 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.13255639 |
91 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12703854 |
92 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.11554598 |
93 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.10021442 |
94 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.08969923 |
95 | * P68_20966046_ChIP-Seq_HELA_Human | 1.08812794 |
96 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.08153226 |
97 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.07429921 |
98 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07249887 |
99 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.06159875 |
100 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.06059684 |
101 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.05775270 |
102 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.05644152 |
103 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.05532149 |
104 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.05450703 |
105 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.05373205 |
106 | MYB_26560356_Chip-Seq_TH2_Human | 1.04034709 |
107 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.03871956 |
108 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03552329 |
109 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.02750347 |
110 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.02427341 |
111 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.02127718 |
112 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.01999479 |
113 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.01850744 |
114 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.01482527 |
115 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00878753 |
116 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.00316577 |
117 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00215902 |
118 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.00173689 |
119 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.00071598 |
120 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.00050280 |
121 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.99990667 |
122 | MYB_26560356_Chip-Seq_TH1_Human | 0.99936482 |
123 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.99610672 |
124 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98978326 |
125 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.98647857 |
126 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.98477628 |
127 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 0.96758400 |
128 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.96559007 |
129 | GATA1_19941826_ChIP-Seq_K562_Human | 0.96076705 |
130 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.95652709 |
131 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.92987589 |
132 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.92678438 |
133 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.92225464 |
134 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.92096081 |
135 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.91332121 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003303_peritoneal_inflammation | 4.28110389 |
2 | MP0003705_abnormal_hypodermis_morpholog | 4.23685167 |
3 | MP0010352_gastrointestinal_tract_polyps | 3.50131732 |
4 | MP0005076_abnormal_cell_differentiation | 3.30880243 |
5 | MP0005451_abnormal_body_composition | 3.01322473 |
6 | MP0010234_abnormal_vibrissa_follicle | 2.71862989 |
7 | MP0009278_abnormal_bone_marrow | 2.68719461 |
8 | MP0003300_gastrointestinal_ulcer | 2.67626636 |
9 | MP0010307_abnormal_tumor_latency | 2.34149238 |
10 | MP0003191_abnormal_cellular_cholesterol | 2.32761986 |
11 | MP0008260_abnormal_autophagy | 2.31888640 |
12 | MP0003566_abnormal_cell_adhesion | 2.25916497 |
13 | MP0004185_abnormal_adipocyte_glucose | 2.23484124 |
14 | MP0004510_myositis | 2.03163305 |
15 | MP0002419_abnormal_innate_immunity | 2.00313815 |
16 | MP0003724_increased_susceptibility_to | 1.98180211 |
17 | MP0004859_abnormal_synaptic_plasticity | 1.92479967 |
18 | MP0005025_abnormal_response_to | 1.86235870 |
19 | MP0002148_abnormal_hypersensitivity_rea | 1.70007148 |
20 | MP0009785_altered_susceptibility_to | 1.66727734 |
21 | MP0004957_abnormal_blastocyst_morpholog | 1.66518202 |
22 | MP0001730_embryonic_growth_arrest | 1.65203444 |
23 | MP0008961_abnormal_basal_metabolism | 1.62736405 |
24 | MP0001533_abnormal_skeleton_physiology | 1.62590984 |
25 | MP0003763_abnormal_thymus_physiology | 1.60314570 |
26 | MP0000350_abnormal_cell_proliferation | 1.58864175 |
27 | MP0003111_abnormal_nucleus_morphology | 1.55705507 |
28 | MP0004808_abnormal_hematopoietic_stem | 1.53841028 |
29 | MP0001545_abnormal_hematopoietic_system | 1.51068387 |
30 | MP0005397_hematopoietic_system_phenotyp | 1.51068387 |
31 | MP0004858_abnormal_nervous_system | 1.49923198 |
32 | MP0008438_abnormal_cutaneous_collagen | 1.44891676 |
33 | MP0005623_abnormal_meninges_morphology | 1.44571215 |
34 | MP0002086_abnormal_extraembryonic_tissu | 1.44345551 |
35 | MP0005671_abnormal_response_to | 1.44229307 |
36 | MP0003091_abnormal_cell_migration | 1.44052000 |
37 | MP0002998_abnormal_bone_remodeling | 1.44006954 |
38 | MP0001849_ear_inflammation | 1.42806337 |
39 | MP0003436_decreased_susceptibility_to | 1.40246901 |
40 | MP0005167_abnormal_blood-brain_barrier | 1.37484991 |
41 | MP0000685_abnormal_immune_system | 1.36321399 |
42 | MP0002084_abnormal_developmental_patter | 1.36199640 |
43 | MP0000733_abnormal_muscle_development | 1.35581194 |
44 | MP0002796_impaired_skin_barrier | 1.33939987 |
45 | MP0003077_abnormal_cell_cycle | 1.33585932 |
46 | MP0000604_amyloidosis | 1.33339623 |
47 | MP0004197_abnormal_fetal_growth/weight/ | 1.32751429 |
48 | MP0000490_abnormal_crypts_of | 1.32315945 |
49 | MP0001697_abnormal_embryo_size | 1.31063359 |
50 | MP0001672_abnormal_embryogenesis/_devel | 1.30000256 |
51 | MP0005380_embryogenesis_phenotype | 1.30000256 |
52 | MP0003329_amyloid_beta_deposits | 1.29704999 |
53 | MP0002398_abnormal_bone_marrow | 1.29006197 |
54 | MP0002088_abnormal_embryonic_growth/wei | 1.25691808 |
55 | MP0004233_abnormal_muscle_weight | 1.25519811 |
56 | MP0001853_heart_inflammation | 1.25350200 |
57 | MP0003984_embryonic_growth_retardation | 1.25319344 |
58 | MP0005023_abnormal_wound_healing | 1.22247590 |
59 | MP0003453_abnormal_keratinocyte_physiol | 1.21021073 |
60 | MP0003693_abnormal_embryo_hatching | 1.20096025 |
61 | MP0004947_skin_inflammation | 1.19453375 |
62 | MP0000343_altered_response_to | 1.18385565 |
63 | MP0001845_abnormal_inflammatory_respons | 1.18156315 |
64 | MP0002080_prenatal_lethality | 1.17847539 |
65 | MP0003448_altered_tumor_morphology | 1.17788102 |
66 | MP0001800_abnormal_humoral_immune | 1.17097430 |
67 | MP0000703_abnormal_thymus_morphology | 1.16350454 |
68 | MP0006082_CNS_inflammation | 1.15964533 |
69 | MP0004130_abnormal_muscle_cell | 1.15670438 |
70 | MP0003221_abnormal_cardiomyocyte_apopto | 1.14380697 |
71 | MP0010630_abnormal_cardiac_muscle | 1.13979799 |
72 | MP0002085_abnormal_embryonic_tissue | 1.12850184 |
73 | MP0008770_decreased_survivor_rate | 1.12683628 |
74 | MP0005257_abnormal_intraocular_pressure | 1.12656308 |
75 | MP0002877_abnormal_melanocyte_morpholog | 1.11658233 |
76 | MP0009333_abnormal_splenocyte_physiolog | 1.11576660 |
77 | MP0002722_abnormal_immune_system | 1.11523770 |
78 | MP0004087_abnormal_muscle_fiber | 1.11354905 |
79 | MP0003123_paternal_imprinting | 1.09589112 |
80 | MP0000689_abnormal_spleen_morphology | 1.09106342 |
81 | MP0003828_pulmonary_edema | 1.07513925 |
82 | MP0002452_abnormal_antigen_presenting | 1.07123277 |
83 | MP0003075_altered_response_to | 1.06898081 |
84 | MP0003172_abnormal_lysosome_physiology | 1.06265363 |
85 | MP0000751_myopathy | 1.05159578 |
86 | MP0002405_respiratory_system_inflammati | 1.04873083 |
87 | MP0001348_abnormal_lacrimal_gland | 1.04541045 |
88 | MP0000750_abnormal_muscle_regeneration | 1.03543122 |
89 | MP0002019_abnormal_tumor_incidence | 1.03202146 |
90 | MP0003279_aneurysm | 1.02887119 |
91 | MP0000858_altered_metastatic_potential | 1.02763746 |
92 | MP0005310_abnormal_salivary_gland | 1.01876781 |
93 | MP0003283_abnormal_digestive_organ | 1.00318503 |
94 | MP0001915_intracranial_hemorrhage | 0.99664965 |
95 | MP0008469_abnormal_protein_level | 0.98921563 |
96 | MP0001790_abnormal_immune_system | 0.98195742 |
97 | MP0005387_immune_system_phenotype | 0.98195742 |
98 | MP0000747_muscle_weakness | 0.98066734 |
99 | MP0003119_abnormal_digestive_system | 0.96662815 |
100 | MP0002396_abnormal_hematopoietic_system | 0.96363471 |
101 | MP0005501_abnormal_skin_physiology | 0.96085390 |
102 | MP0001819_abnormal_immune_cell | 0.95780148 |
103 | MP0002420_abnormal_adaptive_immunity | 0.95407015 |
104 | MP0005409_darkened_coat_color | 0.94704161 |
105 | MP0001873_stomach_inflammation | 0.94568086 |
106 | MP0002925_abnormal_cardiovascular_devel | 0.94110155 |
107 | MP0005666_abnormal_adipose_tissue | 0.93835780 |
108 | MP0000716_abnormal_immune_system | 0.92595918 |
109 | MP0003183_abnormal_peptide_metabolism | 0.89993962 |
110 | MP0002254_reproductive_system_inflammat | 0.89255895 |
111 | MP0001216_abnormal_epidermal_layer | 0.87905532 |
112 | MP0002429_abnormal_blood_cell | 0.87859636 |
113 | MP0001851_eye_inflammation | 0.87834141 |
114 | MP0010094_abnormal_chromosome_stability | 0.87634673 |
115 | MP0009840_abnormal_foam_cell | 0.87091862 |
116 | MP0010155_abnormal_intestine_physiology | 0.86946068 |
117 | MP0005058_abnormal_lysosome_morphology | 0.86898075 |
118 | MP0000767_abnormal_smooth_muscle | 0.86517274 |
119 | MP0005464_abnormal_platelet_physiology | 0.86017945 |
120 | MP0005390_skeleton_phenotype | 0.85853571 |
121 | MP0000266_abnormal_heart_morphology | 0.84378206 |
122 | MP0002060_abnormal_skin_morphology | 0.82403768 |
123 | MP0005621_abnormal_cell_physiology | 0.82137006 |
124 | MP0002269_muscular_atrophy | 0.81667545 |
125 | MP0002089_abnormal_postnatal_growth/wei | 0.81068959 |
126 | MP0005000_abnormal_immune_tolerance | 0.79934141 |
127 | MP0001835_abnormal_antigen_presentation | 0.79744567 |
128 | MP0009764_decreased_sensitivity_to | 0.79646976 |
129 | MP0005375_adipose_tissue_phenotype | 0.79327270 |
130 | MP0002723_abnormal_immune_serum | 0.78868021 |
131 | MP0008874_decreased_physiological_sensi | 0.78816952 |
132 | MP0005166_decreased_susceptibility_to | 0.78619731 |
133 | MP0002653_abnormal_ependyma_morphology | 0.78075327 |
134 | MP0000477_abnormal_intestine_morphology | 0.77270501 |
135 | MP0000313_abnormal_cell_death | 0.77121027 |
136 | MP0001958_emphysema | 0.76800169 |
137 | MP0000678_abnormal_parathyroid_gland | 0.76104150 |
138 | MP0009931_abnormal_skin_appearance | 0.72885759 |
139 | MP0003795_abnormal_bone_structure | 0.72626995 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Cerebral aneurysm (HP:0004944) | 4.04296781 |
2 | Hyperacusis (HP:0010780) | 3.65427664 |
3 | Abnormality of macrophages (HP:0004311) | 3.31137049 |
4 | Abnormality of glycolipid metabolism (HP:0010969) | 3.29573625 |
5 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.29573625 |
6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.29573625 |
7 | Recurrent abscess formation (HP:0002722) | 3.02873057 |
8 | Recurrent bacterial skin infections (HP:0005406) | 3.00616307 |
9 | Ulnar bowing (HP:0003031) | 2.85024130 |
10 | Increased density of long bones (HP:0006392) | 2.75128138 |
11 | Annular pancreas (HP:0001734) | 2.70631008 |
12 | Achilles tendon contracture (HP:0001771) | 2.65768832 |
13 | Vertebral compression fractures (HP:0002953) | 2.62787580 |
14 | Dysostosis multiplex (HP:0000943) | 2.57036545 |
15 | Genu recurvatum (HP:0002816) | 2.56068367 |
16 | Insomnia (HP:0100785) | 2.51369492 |
17 | Premature rupture of membranes (HP:0001788) | 2.41928252 |
18 | Abnormality of the lower motor neuron (HP:0002366) | 2.41232085 |
19 | Shallow orbits (HP:0000586) | 2.40726665 |
20 | Distal upper limb amyotrophy (HP:0007149) | 2.39605252 |
21 | Upper limb amyotrophy (HP:0009129) | 2.39605252 |
22 | Mediastinal lymphadenopathy (HP:0100721) | 2.37638317 |
23 | Loss of speech (HP:0002371) | 2.37246285 |
24 | Distal lower limb amyotrophy (HP:0008944) | 2.34804309 |
25 | Abnormality of the Achilles tendon (HP:0005109) | 2.31734442 |
26 | Thin bony cortex (HP:0002753) | 2.31426573 |
27 | Facial hemangioma (HP:0000329) | 2.27203985 |
28 | Hand muscle atrophy (HP:0009130) | 2.27055286 |
29 | Hematochezia (HP:0002573) | 2.24449971 |
30 | Myositis (HP:0100614) | 2.23789835 |
31 | Dysmetric saccades (HP:0000641) | 2.23707002 |
32 | Cellulitis (HP:0100658) | 2.21758348 |
33 | Orchitis (HP:0100796) | 2.20921296 |
34 | Obstructive lung disease (HP:0006536) | 2.19939414 |
35 | Chronic obstructive pulmonary disease (HP:0006510) | 2.19939414 |
36 | Elfin facies (HP:0004428) | 2.19682808 |
37 | Pointed chin (HP:0000307) | 2.18401837 |
38 | Papilloma (HP:0012740) | 2.17319859 |
39 | Verrucae (HP:0200043) | 2.17319859 |
40 | Cerebral inclusion bodies (HP:0100314) | 2.15362624 |
41 | Polycythemia (HP:0001901) | 2.14513660 |
42 | Gingivitis (HP:0000230) | 2.14077328 |
43 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.12110568 |
44 | Interstitial pulmonary disease (HP:0006530) | 2.11900536 |
45 | Renal duplication (HP:0000075) | 2.11278107 |
46 | Apathy (HP:0000741) | 2.10866426 |
47 | Broad face (HP:0000283) | 2.10785390 |
48 | Long palpebral fissure (HP:0000637) | 2.10299724 |
49 | Neurofibrillary tangles (HP:0002185) | 2.09546038 |
50 | Gastrointestinal stroma tumor (HP:0100723) | 2.08914476 |
51 | Basal cell carcinoma (HP:0002671) | 2.08725053 |
52 | Hypercortisolism (HP:0001578) | 2.08663066 |
53 | Spontaneous hematomas (HP:0007420) | 2.08340602 |
54 | Mitral valve prolapse (HP:0001634) | 2.07951368 |
55 | Ependymoma (HP:0002888) | 2.05678265 |
56 | Short 1st metacarpal (HP:0010034) | 2.05419102 |
57 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 2.05419102 |
58 | Axonal loss (HP:0003447) | 2.04497645 |
59 | Heterotopia (HP:0002282) | 2.04358768 |
60 | Difficulty climbing stairs (HP:0003551) | 2.03916311 |
61 | Disinhibition (HP:0000734) | 2.02757961 |
62 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.01756754 |
63 | Overriding aorta (HP:0002623) | 2.01095461 |
64 | Diminished motivation (HP:0000745) | 2.00862380 |
65 | Myocardial infarction (HP:0001658) | 2.00123135 |
66 | Emphysema (HP:0002097) | 1.99861685 |
67 | Abnormality of the astrocytes (HP:0100707) | 1.99067661 |
68 | Astrocytoma (HP:0009592) | 1.99067661 |
69 | Distal lower limb muscle weakness (HP:0009053) | 1.98621952 |
70 | Enlarged penis (HP:0000040) | 1.95538713 |
71 | Neuronal loss in central nervous system (HP:0002529) | 1.95431225 |
72 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.95291453 |
73 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.95138326 |
74 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.95138326 |
75 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.95138326 |
76 | Hypertensive crisis (HP:0100735) | 1.93629914 |
77 | Aneurysm (HP:0002617) | 1.93348094 |
78 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.92766042 |
79 | Mucopolysacchariduria (HP:0008155) | 1.92694848 |
80 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.92694848 |
81 | Polygenic inheritance (HP:0010982) | 1.92126246 |
82 | Disproportionate tall stature (HP:0001519) | 1.90024599 |
83 | Flat acetabular roof (HP:0003180) | 1.89697466 |
84 | Renovascular hypertension (HP:0100817) | 1.89387168 |
85 | Macroorchidism (HP:0000053) | 1.88664284 |
86 | Slow saccadic eye movements (HP:0000514) | 1.88365853 |
87 | Angiofibromas (HP:0010615) | 1.86964341 |
88 | Adenoma sebaceum (HP:0009720) | 1.86964341 |
89 | Upper motor neuron abnormality (HP:0002127) | 1.86764896 |
90 | Recurrent viral infections (HP:0004429) | 1.85122998 |
91 | Amyotrophic lateral sclerosis (HP:0007354) | 1.84983048 |
92 | Vertebral arch anomaly (HP:0008438) | 1.84864137 |
93 | Bone pain (HP:0002653) | 1.84157729 |
94 | Obstructive sleep apnea (HP:0002870) | 1.83998226 |
95 | Hemorrhage of the eye (HP:0011885) | 1.83885747 |
96 | Meningitis (HP:0001287) | 1.83124523 |
97 | Difficulty running (HP:0009046) | 1.83013744 |
98 | Colitis (HP:0002583) | 1.82619000 |
99 | Increased nuchal translucency (HP:0010880) | 1.82159685 |
100 | Frequent falls (HP:0002359) | 1.82055000 |
101 | Bowel diverticulosis (HP:0005222) | 1.81901300 |
102 | Increased connective tissue (HP:0009025) | 1.81457830 |
103 | Papilledema (HP:0001085) | 1.80822120 |
104 | Vacuolated lymphocytes (HP:0001922) | 1.79723532 |
105 | Abnormality of the thoracic spine (HP:0100711) | 1.79678743 |
106 | Urticaria (HP:0001025) | 1.78440852 |
107 | Striae distensae (HP:0001065) | 1.78349073 |
108 | Eczematoid dermatitis (HP:0000976) | 1.78021532 |
109 | Protrusio acetabuli (HP:0003179) | 1.76728222 |
110 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.76487247 |
111 | Dilatation of the ascending aorta (HP:0005111) | 1.76334930 |
112 | Abnormality of the 1st metacarpal (HP:0010009) | 1.76072106 |
113 | Thoracic kyphosis (HP:0002942) | 1.75798997 |
114 | Rectal prolapse (HP:0002035) | 1.75790524 |
115 | Supranuclear gaze palsy (HP:0000605) | 1.75657203 |
116 | Gastrointestinal infarctions (HP:0005244) | 1.75408738 |
117 | Nuclear cataract (HP:0100018) | 1.75359189 |
118 | Bowed forearm bones (HP:0003956) | 1.74491575 |
119 | Bowing of the arm (HP:0006488) | 1.74491575 |
120 | Amyloidosis (HP:0011034) | 1.74421764 |
121 | Recurrent skin infections (HP:0001581) | 1.74371340 |
122 | Pustule (HP:0200039) | 1.74048549 |
123 | Increased IgE level (HP:0003212) | 1.73771902 |
124 | Recurrent fungal infections (HP:0002841) | 1.73423355 |
125 | Systemic lupus erythematosus (HP:0002725) | 1.73118392 |
126 | Autoimmune thrombocytopenia (HP:0001973) | 1.72760895 |
127 | Fibroma (HP:0010614) | 1.72652219 |
128 | Retrobulbar optic neuritis (HP:0100654) | 1.71854643 |
129 | Optic neuritis (HP:0100653) | 1.71854643 |
130 | Rapidly progressive (HP:0003678) | 1.71635712 |
131 | Vasculitis (HP:0002633) | 1.71505800 |
132 | Increased serum ferritin (HP:0003281) | 1.71374104 |
133 | Fatigue (HP:0012378) | 1.71110692 |
134 | Hyperparathyroidism (HP:0000843) | 1.70046121 |
135 | Prominent nose (HP:0000448) | 1.69446390 |
136 | Cutaneous melanoma (HP:0012056) | 1.69232753 |
137 | Hallux valgus (HP:0001822) | 1.69077657 |
138 | Asymmetry of the thorax (HP:0001555) | 1.67355959 |
139 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.67061068 |
140 | Osteolytic defects of the hand bones (HP:0009699) | 1.67061068 |
141 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.67057880 |
142 | Personality changes (HP:0000751) | 1.67003258 |
143 | Increased CSF protein (HP:0002922) | 1.66373681 |
144 | Bladder diverticulum (HP:0000015) | 1.65937524 |
145 | Syringomyelia (HP:0003396) | 1.64558771 |
146 | Spinal cord lesions (HP:0100561) | 1.64558771 |
147 | Blue sclerae (HP:0000592) | 1.63907881 |
148 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.63744358 |
149 | Fibrous tissue neoplasm (HP:0012316) | 1.63619718 |
150 | Ankle contracture (HP:0006466) | 1.63434353 |
151 | Resting tremor (HP:0002322) | 1.63223071 |
152 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.63191171 |
153 | Gastrointestinal carcinoma (HP:0002672) | 1.63191171 |
154 | Subacute progressive viral hepatitis (HP:0006572) | 1.63186591 |
155 | Abnormality of the peritoneum (HP:0002585) | 1.62919255 |
156 | Cervical subluxation (HP:0003308) | 1.62320806 |
157 | Mitral regurgitation (HP:0001653) | 1.62195399 |
158 | Deviation of the hallux (HP:0010051) | 1.61777710 |
159 | Multiple enchondromatosis (HP:0005701) | 1.61151911 |
160 | Pseudobulbar signs (HP:0002200) | 1.60504769 |
161 | Deep palmar crease (HP:0006191) | 1.60248052 |
162 | Gastrointestinal inflammation (HP:0004386) | 1.59023650 |
163 | Radial bowing (HP:0002986) | 1.58728218 |
164 | Increased cerebral lipofuscin (HP:0011813) | 1.58651574 |
165 | Spinal muscular atrophy (HP:0007269) | 1.58071959 |
166 | Broad palm (HP:0001169) | 1.57290639 |
167 | Abnormality of the nasal mucosa (HP:0000433) | 1.56654171 |
168 | Short phalanx of the thumb (HP:0009660) | 1.55932535 |
169 | Abnormality of the motor neurons (HP:0002450) | 1.55779165 |
170 | Abnormal neuron morphology (HP:0012757) | 1.55779165 |
171 | EMG: neuropathic changes (HP:0003445) | 1.55379231 |
172 | Ankyloglossia (HP:0010296) | 1.53851543 |
173 | High pitched voice (HP:0001620) | 1.53693512 |
174 | Arnold-Chiari malformation (HP:0002308) | 1.53497073 |
175 | Lower limb amyotrophy (HP:0007210) | 1.52286945 |
176 | Bicuspid aortic valve (HP:0001647) | 1.51867827 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TRIB3 | 4.77458613 |
2 | PRPF4B | 3.84733523 |
3 | PKN2 | 3.77375606 |
4 | MAP3K10 | 3.43933787 |
5 | EEF2K | 3.37020349 |
6 | IRAK3 | 3.18380464 |
7 | SMG1 | 2.83319489 |
8 | CDK12 | 2.69247833 |
9 | MAP4K1 | 2.41168477 |
10 | ALK | 2.39140476 |
11 | SIK1 | 2.23749159 |
12 | MAP3K9 | 2.23558955 |
13 | TAOK1 | 2.20728438 |
14 | NME2 | 1.95850817 |
15 | TYRO3 | 1.94303951 |
16 | TAOK2 | 1.93902056 |
17 | IRAK4 | 1.81371946 |
18 | MAP3K14 | 1.80323947 |
19 | GRK6 | 1.79647898 |
20 | BMX | 1.79493325 |
21 | TTN | 1.79291947 |
22 | KSR2 | 1.78376534 |
23 | LATS2 | 1.73964391 |
24 | MAP3K13 | 1.69992055 |
25 | STK10 | 1.66784275 |
26 | MAP3K3 | 1.65790108 |
27 | ICK | 1.57749176 |
28 | MAP3K11 | 1.57681923 |
29 | LRRK2 | 1.57240708 |
30 | SCYL2 | 1.49297988 |
31 | FGFR4 | 1.39144503 |
32 | RIPK1 | 1.38930734 |
33 | EPHB1 | 1.38409555 |
34 | PDGFRA | 1.34599689 |
35 | SIK2 | 1.33467474 |
36 | SIK3 | 1.33148437 |
37 | DMPK | 1.32102932 |
38 | ERN1 | 1.31104436 |
39 | ARAF | 1.25046890 |
40 | NEK2 | 1.16856711 |
41 | PTK6 | 1.12311438 |
42 | CDK6 | 1.12020702 |
43 | TESK1 | 1.07993025 |
44 | CAMKK1 | 1.07660945 |
45 | DDR2 | 1.05616580 |
46 | PAK6 | 1.05446786 |
47 | PRKD3 | 1.04334779 |
48 | MAP3K6 | 1.00240565 |
49 | NEK1 | 1.00011250 |
50 | MOS | 0.97916402 |
51 | PAK4 | 0.97834517 |
52 | MARK2 | 0.97216899 |
53 | MAP3K8 | 0.94278485 |
54 | FGR | 0.93667385 |
55 | IRAK2 | 0.92410290 |
56 | TGFBR2 | 0.90603272 |
57 | CDK4 | 0.87043437 |
58 | RIPK4 | 0.86831413 |
59 | RET | 0.85331370 |
60 | CDC7 | 0.84235493 |
61 | MTOR | 0.84123727 |
62 | ZAP70 | 0.83649114 |
63 | EPHA2 | 0.83497610 |
64 | CSK | 0.81005055 |
65 | BLK | 0.79846208 |
66 | PTK2 | 0.78353370 |
67 | MAP2K3 | 0.77588969 |
68 | STK38 | 0.77547809 |
69 | PRKD2 | 0.76864882 |
70 | CSF1R | 0.70436003 |
71 | RPS6KA4 | 0.69962931 |
72 | PIM2 | 0.69325447 |
73 | RPS6KB2 | 0.69235102 |
74 | PIM1 | 0.69146228 |
75 | TYK2 | 0.68502259 |
76 | HCK | 0.65952805 |
77 | STK11 | 0.65151106 |
78 | TGFBR1 | 0.64350975 |
79 | TESK2 | 0.63918629 |
80 | IKBKE | 0.61468360 |
81 | FES | 0.60628437 |
82 | DAPK2 | 0.60369809 |
83 | FGFR3 | 0.59721622 |
84 | PDGFRB | 0.59513989 |
85 | JAK2 | 0.59134331 |
86 | BRAF | 0.58354957 |
87 | KSR1 | 0.57919833 |
88 | PRKCH | 0.57863664 |
89 | BTK | 0.56995542 |
90 | PDK1 | 0.55565715 |
91 | CDC42BPA | 0.54777808 |
92 | RAF1 | 0.53656527 |
93 | DAPK1 | 0.53295877 |
94 | RPS6KA1 | 0.51736291 |
95 | IKBKB | 0.51244494 |
96 | LATS1 | 0.50270889 |
97 | CAMK1D | 0.49714817 |
98 | PAK2 | 0.49072821 |
99 | MATK | 0.48883167 |
100 | RPS6KA2 | 0.48670954 |
101 | ILK | 0.48252081 |
102 | MAPK12 | 0.44875202 |
103 | HIPK2 | 0.43483628 |
104 | STK3 | 0.43463391 |
105 | RPS6KL1 | 0.42795632 |
106 | RPS6KC1 | 0.42795632 |
107 | EGFR | 0.42783518 |
108 | NEK9 | 0.41995013 |
109 | DYRK1B | 0.41209548 |
110 | PRKG2 | 0.40907380 |
111 | SYK | 0.40014818 |
112 | MINK1 | 0.39933875 |
113 | MAP3K5 | 0.39050998 |
114 | TBK1 | 0.39027227 |
115 | CAMK1G | 0.38680777 |
116 | RPS6KA6 | 0.38632637 |
117 | CHEK1 | 0.38497345 |
118 | PDPK1 | 0.38236953 |
119 | CHUK | 0.38070055 |
120 | TTK | 0.37391411 |
121 | MAP3K1 | 0.37071790 |
122 | PRKD1 | 0.37059952 |
123 | MAPKAPK2 | 0.37041872 |
124 | CDK2 | 0.36797216 |
125 | MAP3K7 | 0.36602683 |
126 | MAP2K2 | 0.36470156 |
127 | MST1R | 0.36214965 |
128 | JAK1 | 0.36157501 |
129 | MAPKAPK3 | 0.34338711 |
130 | NTRK1 | 0.34254795 |
131 | DAPK3 | 0.33862293 |
132 | MAPK11 | 0.33678066 |
133 | JAK3 | 0.33619050 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Other glycan degradation_Homo sapiens_hsa00511 | 2.43433466 |
2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.31329657 |
3 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.98249853 |
4 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.90214423 |
5 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.88708446 |
6 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.84683308 |
7 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.77375212 |
8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.74742839 |
9 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.66909295 |
10 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.66411906 |
11 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.62784870 |
12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.55504059 |
13 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.53795658 |
14 | Glioma_Homo sapiens_hsa05214 | 1.53264612 |
15 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.49158624 |
16 | Influenza A_Homo sapiens_hsa05164 | 1.44329402 |
17 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.42567374 |
18 | Colorectal cancer_Homo sapiens_hsa05210 | 1.38117748 |
19 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.37750686 |
20 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.37497827 |
21 | Lysosome_Homo sapiens_hsa04142 | 1.36803786 |
22 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.36012848 |
23 | Endometrial cancer_Homo sapiens_hsa05213 | 1.34441946 |
24 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.33723537 |
25 | Prion diseases_Homo sapiens_hsa05020 | 1.31547390 |
26 | Hepatitis C_Homo sapiens_hsa05160 | 1.30226554 |
27 | Malaria_Homo sapiens_hsa05144 | 1.29859972 |
28 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.27029791 |
29 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.24451264 |
30 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.24077053 |
31 | Bladder cancer_Homo sapiens_hsa05219 | 1.19987975 |
32 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.19677214 |
33 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.19532128 |
34 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.19135432 |
35 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.17749845 |
36 | Shigellosis_Homo sapiens_hsa05131 | 1.16019804 |
37 | Viral myocarditis_Homo sapiens_hsa05416 | 1.14999976 |
38 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.13900784 |
39 | Leishmaniasis_Homo sapiens_hsa05140 | 1.13413172 |
40 | Adherens junction_Homo sapiens_hsa04520 | 1.12984444 |
41 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.11762397 |
42 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.10182070 |
43 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.07387468 |
44 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.05902057 |
45 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.05526143 |
46 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.05385786 |
47 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.04602671 |
48 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.04394911 |
49 | Allograft rejection_Homo sapiens_hsa05330 | 1.04122749 |
50 | Legionellosis_Homo sapiens_hsa05134 | 1.03333088 |
51 | Platelet activation_Homo sapiens_hsa04611 | 1.03005667 |
52 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.02881986 |
53 | Focal adhesion_Homo sapiens_hsa04510 | 1.02096158 |
54 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.01684982 |
55 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.01484927 |
56 | Long-term potentiation_Homo sapiens_hsa04720 | 1.01183173 |
57 | Pertussis_Homo sapiens_hsa05133 | 1.01003212 |
58 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.00785900 |
59 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.99514646 |
60 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.99508474 |
61 | Phagosome_Homo sapiens_hsa04145 | 0.99467433 |
62 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.99426705 |
63 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.99096648 |
64 | Thyroid cancer_Homo sapiens_hsa05216 | 0.98993584 |
65 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.98897439 |
66 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.96242149 |
67 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.95820508 |
68 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.95372404 |
69 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.94569197 |
70 | Apoptosis_Homo sapiens_hsa04210 | 0.93376355 |
71 | Hepatitis B_Homo sapiens_hsa05161 | 0.90593342 |
72 | Tuberculosis_Homo sapiens_hsa05152 | 0.90481103 |
73 | * Endocytosis_Homo sapiens_hsa04144 | 0.90407349 |
74 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.89969521 |
75 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.89956107 |
76 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.89892315 |
77 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.88887853 |
78 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.88744136 |
79 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.88580162 |
80 | HTLV-I infection_Homo sapiens_hsa05166 | 0.88164032 |
81 | RNA transport_Homo sapiens_hsa03013 | 0.87886506 |
82 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.86207638 |
83 | Gap junction_Homo sapiens_hsa04540 | 0.86109944 |
84 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.85933183 |
85 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.85605074 |
86 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.85582201 |
87 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.84653366 |
88 | Salmonella infection_Homo sapiens_hsa05132 | 0.83023076 |
89 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.82699099 |
90 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.82660408 |
91 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.80715236 |
92 | Insulin resistance_Homo sapiens_hsa04931 | 0.80208607 |
93 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.79538231 |
94 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.78836156 |
95 | Amoebiasis_Homo sapiens_hsa05146 | 0.78697054 |
96 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.77904094 |
97 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.75428167 |
98 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.75315655 |
99 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.74695267 |
100 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.73826765 |
101 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.73676558 |
102 | Galactose metabolism_Homo sapiens_hsa00052 | 0.73579661 |
103 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.72779419 |
104 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.72673518 |
105 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.72657828 |
106 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.71996462 |
107 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.71608638 |
108 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.71586677 |
109 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.70733254 |
110 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.70453389 |
111 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.70002620 |
112 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.68712629 |
113 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.67187871 |
114 | Cell cycle_Homo sapiens_hsa04110 | 0.66889188 |
115 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.65121284 |
116 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.65010821 |
117 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.64679907 |
118 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.63420883 |
119 | Tight junction_Homo sapiens_hsa04530 | 0.63012320 |
120 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.60910680 |
121 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.60797321 |
122 | Prostate cancer_Homo sapiens_hsa05215 | 0.60632952 |
123 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.60258886 |
124 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.57741581 |
125 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.57531810 |
126 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.57468684 |
127 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.57292603 |
128 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.57155493 |
129 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.56611654 |
130 | Measles_Homo sapiens_hsa05162 | 0.56490792 |
131 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.55945268 |
132 | Pathways in cancer_Homo sapiens_hsa05200 | 0.55759718 |
133 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.55750072 |
134 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.55720756 |